Oncology USP/ Bp Grade Lapatinib CAS No. 231277-92-2

Model NO.
LDKJ12-172
Appearance
White Powder
Shelf Life
2 Years
Storage
Cool Dry Place
Molecular Formula
C29h26clfn4o4s
Einecs
1806241-263-5
CAS
231277-92-2
Transport Package
25kg Carton Drum (32cm*58cm)or 1kg Foil Bag (10cm*
Specification
1kg/bag
Trademark
Lingding
Origin
Hebei, China
Production Capacity
8000kilogram/Per Month
Reference Price
$ 9.00 - 90.00

Product Description

Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2

Product Description

Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2
Product Name: Lapatinib
CAS: 231277-92-2
MF: C29H26ClFN4O4S
MW: 581.06
EINECS: 1806241-263-5

Lapatinib, a new member of the 4-anilinoquinazoline class of RTK inhibitors (RTKIs), was launched as an oral treatment for breast cancer. Lapatinib has dual affinity for EGFR and HER2 tyrosine kinases. It is indicated in combination with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. Previously marketed drugs from the 4-anilinoquinazoline class include erlotinib (Tarceva) and gefitinib (Iressa TM ), both of which are indicated for treating non-small-cell lung cancer (NSCLC). As with erlotinib and gefitinib, To Market, To Market 2007 475 lapatinib is an ATP-competitive kinase inhibitor. It inhibits the tyrosine kinase activity EGFR and HER-2 with apparent Ki values of 3 and 13 nM, respectively, and has slow off-rate kinetics (t1/2X300 min).

Uses
1. Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.

2.antineoplastic, tyrosine kinase inhibitor

3.An antineoplastic agent used in breast cancer research.
Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2
 
Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2
 
Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2
 

Packaging & Shipping

Packaging Details

25kg carton drum (32cm*58cm)or 1kg foil bag (10cm*15cm) or by request of clients

Port:TIANJIN

 

Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2

 

Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2
 

Company Profile

 

Lingding Biotechnology Co., Ltd. is a professional business company ,that include pharmaceutical raw materials, pharmaceutical intermediates,and other more than 1000 products of the enterprise,  The registered capital is 3 million yuan, it is a collection of scientific research, production and sales in one of the enterprises.
Since its establishment, the company has always adhered to the core concept of "focus on products, attentive service", adhere to the business purpose of "innovation, professional, win-win", to provide customers with a full range of meticulous and thoughtful services. We will adhere to the customer's serious and responsible attitude, comply with the standardized operation procedures, with efficient execution to complete customer needs.
The company's products are sold all over the world, mainly exported to the United States, Europe, Southeast Asia, Australia, the Middle East and South Africa and other countries.The company has a strong scientific research and technical team, can provide customers with high quality products and a full range of services. We will provide first-class products and better service to face the needs of customers, to meet the challenges of the market.  Welcome domestic and foreign customers to negotiate.

Oncology USP/Bp Grade Lapatinib CAS No. 231277-92-2

 

 

Our Advantages

 

GOUV.NE, 2023